🇺🇸 FDA
Patent

US 6146628

Biotherapeutic agents comprising recombinant PAP and PAP mutants

expired A61KA61K2039/505A61K47/6825

Quick answer

US patent 6146628 (Biotherapeutic agents comprising recombinant PAP and PAP mutants) held by Regents of the University of Minnesota and Rutgers expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Regents of the University of Minnesota and Rutgers
Grant date
Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K47/6825, A61P, A61P35/00